Nantahala Capital Management, LLC 13D and 13G filings for Akebia Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2021-02-12 06:42 am Purchase |
2020-12-31 | 13G | Akebia Therapeutics, Inc. AKBA |
Nantahala Capital Management, LLC | 7,040,487 4.900% |
303,367![]() (+4.50%) |
Filing |